| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a36c66685971b78daf233b5999ead4c2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-495 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate |
2021-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c68f758f21b296343e3834b9a28d881e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1783deb0d3ae87f6c0268995253cc820
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af1bce49aab6b77c1a1f4707fe7a6508
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_780e5a85d80cf30b1a825ceb5b2cb4dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed27085834a8f644528c8ff750453eef |
| publicationDate |
2022-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022042537-A1 |
| titleOfInvention |
APPLICATION OF COMBINATION OF FUSION PROTEIN OF TGF-β RECEPTOR AND MULTI-TARGETED TYROSINE KINASE INHIBITOR IN PREPARING ANTI-TUMOR DRUG |
| abstract |
Disclosed is an application of a combination of a fusion protein of TGF-β receptor and multi-targeted tyrosine kinase inhibitor in preparing an anti-tumor drug. |
| priorityDate |
2020-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |